CRISPR Screening System for Mutation Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for assessing the effects of genetic sequence variants on phenotypic parameters of cells are laborious, time-consuming, and costly, often resulting in false positive results due to factors like transfection toxicities and off-target effects, and require lengthy clone generation, limiting their clinical and therapeutic applications.

Innovation Solution

A method involving the introduction of a mutation of interest and a synonymous mutation into a cell population using a nuclease, allowing for the simultaneous analysis of hundreds of knock-in cells, which eliminates the need for clone generation and provides a fast, reliable assessment of phenotypic effects through PCR or next-generation sequencing, using internal controls to validate results.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional knock-in experiments using gene-editing technologies are performed with clonal cell population generation, then the functional consequence of mutations can be assessed, but the process is laborious, time-consuming, and expensive with high propensity for false positive results

Engineering Contradiction:
Improveaccuracy of mutation effect assessmentVSAvoidtime for clone generation and analysis
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent segments the cell population into multiple independent cultures, each receiving different oligonucleotide combinations (mutation of interest vs synonymous control). This allows parallel assessment of multiple conditions without requiring sequential clone generation, thereby reducing time while maintaining reliability through statistical comparison across segments

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces synonymous mutations as intermediary control elements that serve as internal references within the same experimental system. These control mutations allow normalization of results to account for experimental variables like transfection efficiency and off-target effects, thereby improving reliability without extending the time required for analysis

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional methods with multiple repeat experiments and individually designed controls are used, then false positive results can be reduced, but labor and material costs increase significantly

Engineering Contradiction:
Improvereduction of false positive resultsVSAvoidcost efficiency of experimentation
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent merges the mutation of interest and synonymous control into a single co-transfection experiment using pooled oligonucleotides. This combines multiple control functions (transfection efficiency, off-target effects, background variability) into one integrated experimental unit, reducing the need for separate repeat experiments and thereby improving cost efficiency while maintaining reliability

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The synonymous mutation serves multiple functions simultaneously: it acts as a control for transfection efficiency, a reference for off-target effect normalization, and a baseline for comparing phenotypic changes. This multi-functionality eliminates the need for multiple specialized controls, reducing both labor and material costs while maintaining experimental reliability

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Measurement precision

If clonal cell lines are generated for mutation analysis, then individual mutation effects can be determined, but the process is inherently lengthy and requires that the mutation allows clone expansion

Engineering Contradiction:
Improvedetermination of individual mutation effectsVSAvoidcomplexity of clone generation process
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses oligonucleotide copies of the desired mutation sequences to introduce changes directly into the genome without requiring physical clone isolation and expansion. By using synthetic oligonucleotides as templates for homology-directed repair, the method bypasses the complex multi-step clone generation process while maintaining precision in determining mutation effects through sequence-specific analysis

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables accurate, fast, and cost-efficient determination of the effects of genetic mutations on cell parameters like proliferation and survival, reducing the time to results from weeks to a few weeks and eliminating the need for lengthy clone generation, while minimizing false positives.

Implementation Method 1

a nuclease or a polynucleotide encoding said nuclease, wherein the nuclease is capable of generating one or more single-strand breaks (SSBs) or double-strand breaks (DSBs) in a target nucleic acid sequence

Methodology Applied
Scientific EffectCRISPR/Cas9 gene editing: Enzyme

Implementation Method 2

determining the effect of the mutation of interest on the parameter of interest... allowing absolute frequencies to be calculated

Methodology Applied
Scientific EffectPCR amplification: Enzyme

Implementation Method 3

In one design of the PCR or next-generation sequencing (NGS) analysis of the introduced mutations, primers are designed to anneal outside the region substantially similar to the oligonucleotides introduced, allowing absolute frequencies to be calculated

Methodology Applied
Scientific EffectNext-generation sequencing:

Data Source

PatentUS20230407377A1Crispr/cas screening system materials and methods
Publication Date: 2023.12.21 UNIVERSITY OF COPENHAGEN
  • US20230407377A1 patent drawing
  • US20230407377A1 patent drawing
  • US20230407377A1 patent drawing

AI summary

The present disclosure relates to methods for assessing the effects of a mutation of interest in a cell. Herein are also disclosed systems for assessing the effects of a mutation of interest in a cell. The disclosure also provides host cells and host cell populations comprising the system.